GLP-1 medications are not automatic disqualifiers
The following data were recorded: demographics, diabetes duration, insulin type, and therapeutic scheme daily dose, number of injections per day, type of needle (length and gauge), needle reuse, injection site rotation, ice-cold insulin injections [6], distance between injection sites (centimeters), intra-LH injections, rate of unexplained hypoglycemia (hypo), blood glucose variability (GV)
Receive a $50 off coupon for your first month
Clinical trials show that while using this medication, people often experience consistent weight reduction over time 1.3 Therapeutic Class and Clinical Relevance Classified under incretin mimetics, semaglutide has redefined therapeutic algorithms in type 2 diabetes management
The decision to use semaglutide for weight loss should always be made in consultation with health experts
According to a clinical trial, individuals using semaglutide at higher doses (1.7 mg and 2.4 mg) experienced 6.9% weight loss after 3 months
